NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

  News | News By Subject | News by Disease News By Date | Search News
 News By Date

SuMoTuWeThFrSa
28123456
78910111213
14151617181920
21222324252627
28293031123
45678910

 Thursday, March 18, 2010
 Top Breaking News
Teva Pharmaceutical Industries Limited (TEVA) to Acquire Ratiopharm for Nearly $5 Billion     More...
Novelos Therapeutics, Inc. (NVLT) Discontinues Current Development Program for NOV-002 in NSCLC; Primary and Secondary Endpoints Not Met in Phase 3 Trial     More...
250 Jobs Gone as Warner Chilcott, PLC (WCRX) Exits Mason, Ohio     More...
UK, Spain Close to Approving GW Pharmaceuticals's Cannabis Drug     More...
Alzheimer Drug Test Result From Johnson & Johnson (JNJ) May Be Pushed Back to 2012     More...
Somaxon Pharmaceuticals, Inc. Announces FDA Approval of Silenor(R) (Doxepin) For The Treatment Of Insomnia     More...
US FDA Staff Says Novartis AG and Astellas Pharma Inc. May Need Wider Eczema Caution for Kids; New Reported Cases of Cancer and Infection     More...
OriGene Technologies, Inc. Raises $16 Million     More...
GlaxoSmithKline (GSK) Up as Novartis Corporation (NVS) Drops Generic Advair in U.S.; Novartis Hands Back U.S. Rights to VR315 to Vectura Limited     More...
Johnson & Johnson (JNJ) CEO Weldon Gets 11% 2009 Raise, to $25.6 Million     More...
More than 1,600 Jobs to be Created in Singapore; Big Commitments Include Roche (RHHBY), Quintiles Transnational Corp., and Medtronic, Inc. (MDT)     More...
Pfizer Inc. (PFE) (JOBS) Drops Viagra Infringement Case Against Eli Lilly and Company (LLY) (JOBS)     More...
Dr. Thomas Hofstaetter Named President and CEO of VaxInnate Corporation     More...
Roche (RHHBY) Aiming to Launch 6 New Products by End 2014     More...
Cardima, Inc. (CRDM); Pentagon Deals Worth up to $356 Million     More...
 Featured Stories
Genes Linked to Ulcerative Colitis Identified At Cedars-Sinai Medical Center     More...
New Attack On Cancer Forces Cells To Grow Old And Die, University of Texas MD Anderson Cancer Center Study     More...
Anti-Obesity Drugs Unlikely To Provide Lasting Benefit According To University of Liverpool Scientists     More...
Hypnotherapy 'Can Help' Irritable Bowel Syndrome, Gloucestershire Royal Hospital Study     More...
Selenium Protects Men Against Diabetes, University of Montpellier Study Suggests     More...
Lipidemia Improves with Growth Hormone Tx, King's College London Study     More...
Drug Dramatically Reduces Nausea and Vomiting in Bone Marrow Transplant Patients, Loyola University Study     More...
Age Likely A Factor In Colon Cancer Chemotherapy, Harvard Medical School Study     More...
Senator Asks Drugmakers To Explain Prices     More...
 More News
Pharming Group (PHGUF.PK) Submits Response To Questions MAA Rhucin     More...
Antisoma PLC (ASM.L) Initiates Phase IIb Trial Of AS1411 In Acute Myeloid Leukaemia     More...
GlobeImmune, Inc. Announces Presentations of GI-5005 Phase 2b Data at EASL 2010 Meeting     More...
Ovatech(TM) Reports Enrollment is Closed for Phase 2 Clinical Trial of Ovaprene(TM) Non-Hormonal Intravaginal Contraceptive Ring at New York Downtown Hospital (NYDH)     More...
MediciNova, Inc. Reports Positive Preliminary Results From a Phase Ib Clinical Trial of MN-221 in Moderate to Severe COPD Patients     More...
Celsion Corporation (CLN) Announces ThermoDox(R) Abstract Accepted for Presentation at the American Society of Clinical Oncology 2010 Annual Meeting     More...
CPEX Pharmaceuticals Announces Preliminary Results from its Phase 2a Clinical Trial of Nasulin(TM)     More...
PolyMedix Inc. Initiates Phase 1B Clinical Study With PMX-60056 To Reverse Low Molecular Weight Heparin     More...
International Stem Cell Corporation Begins Its Second Pre-Clinical Phase of Testing Retinal Pigment Epithelium (RPE) Derived from Human Parthenogenetic Stem Cells for Treatment of Retinal Diseases     More...
Actavis Receives Approval of Alprazolam ODT in the U.S.     More...
Advaxis, Inc. Research In ActA Shows Therapeutic Anti-Cancer Response     More...
Greenberg Traurig Maher Advises on US$330 Million Sale of ApaTech Ltd to Baxter International, Inc. (BAX)     More...
Genocea Biosciences Signs Exclusive License Agreement with Children's Hospital Boston for Novel Streptococcus Pneumoniae Antigens     More...
PPD, Inc. (PPDI) and Southern Research Institute Sign Agreement for Pandemic and Seasonal Influenza Vaccine Clinical Research Services     More...
SurModics Inc. (SRDX) Licenses Ophthalmology Technology to ForSight Labs, LLC     More...
H. Lee Moffitt Cancer Center & Research Institute Signs Licensing Agreement with Proteacel, LLC     More...
Emisphere Technologies, Inc. (EMIS) and Alchemia to Research an Oral Formulation of Fondaparinux with Eligen(R) Technology     More...
EnteroMedics (ETRM) Extends Neuroblocking Technology Research and Development Collaboration With Mayo Clinic     More...
CellaVision AB And Sysmex Corporation Enhance Partnership By Signing A Global Distribution Agreement     More...
Vectura Limited and Sandoz Pharmaceuticals Revise VR315 Agreement; Vectura to Receive $9.5 Million Payment and up to $25 Million Loan Facility     More...
Centene Corporation's Arizona Behavioral Health Unit Awarded Expanded Contract     More...
Achillion Pharmaceuticals, Inc. Announces Award of National Institutes of Health (NIH) Grant to Study Unique Antibacterial Compound Series     More...
Statement From Eli Lilly and Company (LLY) Regarding Stolen Company Products From Enfield, Connecticut Distribution Operations     More...
China Sky One Medical, Inc. Announces Antroquinonol Capsule Recognized as Breakthrough Drug by Chinese Ministry of Science and Technology     More...
Med Gen (MGNI) Inks Multi-Million Dollar Funding Deal     More...
Kendle International (KNDL) Announces New Revolving Credit Facility     More...
Capital Valmoris Inc., BioTonix and Sylvain Guimond Announce the Closing of Their Qualifying Transaction and $2,500,000 Public Financing of Valmoris     More...
Valeant Pharmaceuticals International (VRX) Announces Annual Stockholder Meeting Date     More...
Nuvo Research Inc. (NRI.TO) Completes Redemption of 5% Convertible Debentures     More...
ARCA biopharma Announces Receipt of NASDAQ Notice per NASDAQ Rule 5810(b)     More...
AVEO Pharmaceuticals, Inc. (AVEO) Completes Initial Public Offering     More...
Rigel Pharmaceuticals, Inc. (RIGL) to Webcast Investor Day on March 25, 2010     More...
NeoStem, Inc. Announces Warrant Exercise by Principal Shareholder     More...
Cardima, Inc. (CRDM) Applies for Listing on NASDAQ Stock Market     More...
Aastrom Biosciences, Inc. (ASTM) Ticker Symbol Reverts to ASTM     More...
Harbor BioSciences, Inc.  (HRBR) Announces Listing Transfer to The Nasdaq Capital Market     More...
Norgen Biotek Corporation Transitions into Diagnostics with the Launch of over 30 New Kits for Nucleic Acid-Based Diagnostics     More...
DPT Laboratories, Ltd. Executes Strategic Initiative to Create New Centers of Excellence     More...
ChemImage's Raman Chemical Imaging Used for Ingredient-Specific Particle Sizing for Inhalation Product Development     More...
BioImagene, Inc. Announces Integration with Market-Leading Anatomic Pathology Laboratory Information Systems     More...
BioSense Technologies' Novel Diagnostic Testing Platform for Rapid Drug Susceptibility Presented at the National Foundation for Infectious Diseases 2010 Annual Conference     More...
Targeted Sequencing in Maize Genome Utilizing a Novel Two-Stage Sequence Capture Method with Roche NimbleGen, Inc Arrays and 454 Sequencing Systems     More...
CombinatoRx, Incorporated (CRXX) to Webcast Conference Call Discussing Fourth Quarter and Year End 2009 Financial Results     More...
Cyclacel Pharmaceuticals, Inc. (CYCC) to Announce Fourth Quarter 2009 Financial Results on March 23, 2010     More...
Champions Biotechnology, Inc. (CSBR) Reports Fiscal 2010 Third Quarter Financial Results     More...
Icagen, Inc. (ICGN) to Announce Fourth Quarter and Full Year 2009 Results and Conduct Conference Call on March 30, 2010     More...
NeoPharm (NEOL) Announces Fourth Quarter And Full Year 2009 Financial Results     More...
OctoPlus Announces 2009 Annual Results Meeting Revenue Guidance Of Euro 19 Million     More...
Precise Biometrics AB Receives Order Worth SEK 4.3 Million (604,017 USD)     More...
Synergetics, Inc. Announces Second Quarter Results     More...
Somaxon Pharmaceuticals, Inc. Reports 2009 Full Year Financial Results     More...
ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter and Year Ended December 31, 2009 and to Provide a Business Update     More...
Warnex Inc. (CC:WNX) Reports Fourth Quarter and Year End 2009 Results     More...
ZIOPHARM, Inc. Reports Fourth Quarter and Full Year 2009 Financial Results     More...
Lauren Stewart is new Vice President, Quality Standards and Corporate Compliance at Sentrx     More...
Marc Kamin, M.D. Joins PharmaNet Development Group, Inc. as Vice President, Medical and Scientific Affairs, Neuroscience     More...
European Society of Human Reproduction and Embryology 26th Annual Meeting, 27-30 June 2010     More...
Gilead Sciences, Inc. (GILD) to Present at the Barclays Capital 2010 Global Healthcare Conference on Wednesday, March 24     More...
Celgene Corporation (CELG) to Present at the Barclays Capital 2010 Global Healthcare Conference     More...
Regeneron Pharmaceuticals, Inc. (REGN) Announces Presentation at the Barclays Capital Global 2010 Healthcare Conference     More...
Idenix Pharmaceuticals, Inc. (IDIX) to Present at the Barclays Capital 2010 Global Healthcare Conference     More...
DURECT Corporation (DRRX) to Present at the Barclays Capital Global Healthcare Conference     More...